$5.84 Billion is the total value of Eventide Asset Management's 161 reported holdings in Q2 2024. The portfolio turnover from Q1 2024 to Q2 2024 was 20.4% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
TT | Buy | TRANE TECHNOLOGIES PLC | $264,953,773 | +10.0% | 805,502 | +0.4% | 4.54% | +20.1% |
TMDX | Sell | TRANSMEDICS GROUP INC | $172,524,667 | +99.4% | 1,145,430 | -2.1% | 2.95% | +117.8% |
WCN | Buy | WASTE CONNECTIONS INC | $141,531,127 | +2.0% | 807,089 | +0.0% | 2.42% | +11.4% |
ROP | Buy | ROPER TECHNOLOGIES INC | $141,229,522 | +1.4% | 250,558 | +0.9% | 2.42% | +10.7% |
ODFL | Buy | OLD DOMINION FREIGHT LINE IN | $132,825,452 | -19.1% | 752,126 | +0.4% | 2.27% | -11.7% |
DDOG | Buy | DATADOG INC | $132,443,319 | +5.4% | 1,021,230 | +0.5% | 2.27% | +15.1% |
TTD | Sell | THE TRADE DESK INC | $127,304,543 | -3.8% | 1,303,415 | -13.9% | 2.18% | +5.0% |
MIRM | Buy | MIRUM PHARMACEUTICALS INC | $123,590,696 | +49.1% | 3,614,820 | +9.5% | 2.12% | +62.8% |
CLDX | Buy | CELLDEX THERAPEUTICS INC NEW | $123,137,155 | -5.9% | 3,327,132 | +6.7% | 2.11% | +2.7% |
DHI | Buy | D R HORTON INC | $117,471,920 | -9.4% | 833,548 | +5.8% | 2.01% | -1.1% |
GH | Sell | GUARDANT HEALTH INC | $108,604,337 | +26.0% | 3,760,538 | -10.0% | 1.86% | +37.5% |
LRCX | Buy | LAM RESEARCH CORP | $107,510,451 | +16.9% | 100,963 | +6.7% | 1.84% | +27.6% |
MTD | Buy | METTLER TOLEDO INTERNATIONAL | $102,897,564 | +5.4% | 73,625 | +0.4% | 1.76% | +15.0% |
CRWD | Buy | CROWDSTRIKE HLDGS INCcl a | $95,777,574 | +19.6% | 249,948 | +0.1% | 1.64% | +30.5% |
ARGX | Buy | ARGENX SEsponsored adr | $94,155,108 | +9.3% | 218,945 | +0.0% | 1.61% | +19.3% |
IDXX | Sell | IDEXX LABS INC | $91,751,453 | -23.8% | 188,324 | -15.5% | 1.57% | -16.7% |
POOL | Buy | POOL CORP | $88,227,374 | -23.7% | 287,077 | +0.1% | 1.51% | -16.8% |
COLL | Buy | COLLEGIUM PHARMACEUTICAL INC | $84,835,923 | -17.0% | 2,634,656 | +0.0% | 1.45% | -9.4% |
Buy | TOAST INCcl a | $83,378,294 | +3.5% | 3,235,479 | +0.0% | 1.43% | +12.9% | |
ROL | Buy | ROLLINS INC | $83,194,073 | +33.7% | 1,705,146 | +26.8% | 1.42% | +46.1% |
MPWR | Buy | MONOLITHIC PWR SYS INC | $81,020,113 | +21.3% | 98,603 | +0.0% | 1.39% | +32.5% |
MNDY | Sell | MONDAY COM LTD | $76,782,457 | -14.9% | 318,917 | -20.2% | 1.31% | -7.1% |
AXSM | Buy | AXSOME THERAPEUTICS INC | $75,566,477 | +173.1% | 938,714 | +170.7% | 1.29% | +198.2% |
PANW | Sell | PALO ALTO NETWORKS INC | $72,877,997 | +19.1% | 214,973 | -0.1% | 1.25% | +30.1% |
EVH | Buy | EVOLENT HEALTH INCcl a | $71,491,955 | -17.5% | 3,739,119 | +41.5% | 1.22% | -9.9% |
XMTR | Buy | XOMETRY INC | $69,597,755 | -18.8% | 6,020,567 | +18.6% | 1.19% | -11.4% |
HUBS | Sell | HUBSPOT INC | $69,006,020 | -22.2% | 117,001 | -17.4% | 1.18% | -15.1% |
TRGP | Buy | TARGA RES CORP | $65,908,831 | +24.7% | 511,794 | +8.4% | 1.13% | +36.1% |
LAD | Sell | LITHIA MTRS INC | $62,024,441 | -25.5% | 245,690 | -11.2% | 1.06% | -18.7% |
ASML | Buy | ASML HOLDING N V | $61,480,391 | +5.4% | 60,114 | +0.0% | 1.05% | +15.1% |
LOW | Buy | LOWES COS INC | $60,210,272 | -13.4% | 273,112 | +0.1% | 1.03% | -5.4% |
ENTG | Sell | ENTEGRIS INC | $57,794,407 | -16.8% | 426,842 | -13.6% | 0.99% | -9.2% |
PCVX | Buy | VAXCYTE INC | $55,813,443 | +24.3% | 739,153 | +12.5% | 0.96% | +35.7% |
NVT | Sell | NVENT ELECTRIC PLC | $55,208,077 | -4.8% | 720,638 | -6.3% | 0.94% | +4.0% |
LEXEO THERAPEUTICS INC | $54,041,118 | +2.3% | 3,369,147 | 0.0% | 0.92% | +11.7% | ||
EXAS | Buy | EXACT SCIENCES CORP | $52,040,508 | -30.5% | 1,231,728 | +13.6% | 0.89% | -24.2% |
AJG | Buy | GALLAGHER ARTHUR J & CO | $51,523,600 | +32.0% | 198,695 | +27.2% | 0.88% | +44.1% |
FLYW | Sell | FLYWIRE CORPORATION | $50,357,144 | -51.6% | 3,072,431 | -26.8% | 0.86% | -47.2% |
KLAC | Sell | KLA CORP | $50,109,595 | +3.9% | 60,775 | -11.9% | 0.86% | +13.5% |
ARDX | Sell | ARDELYX INC | $49,402,337 | -0.7% | 6,666,982 | -2.1% | 0.85% | +8.5% |
Buy | GITLAB INC | $48,764,034 | +20.2% | 980,773 | +41.0% | 0.84% | +31.3% | |
TREX | Buy | TREX CO INC | $48,676,531 | -25.7% | 656,726 | +0.0% | 0.83% | -18.9% |
INSM | Buy | INSMED INC | $45,237,395 | +162.5% | 675,185 | +6.3% | 0.77% | +186.7% |
CDW | Buy | CDW CORP | $45,212,099 | -6.6% | 201,984 | +6.8% | 0.77% | +2.0% |
AURA BIOSCIENCES INC | $43,868,276 | -3.7% | 5,802,682 | 0.0% | 0.75% | +5.2% | ||
VST | Buy | VISTRA CORP | $42,457,182 | +63.5% | 493,803 | +32.4% | 0.73% | +78.6% |
FERG | Buy | FERGUSON PLC NEW | $40,784,820 | -3.0% | 210,611 | +9.4% | 0.70% | +5.8% |
CPRT | Buy | COPART INC | $38,646,085 | -6.4% | 713,554 | +0.0% | 0.66% | +2.2% |
WMB | Buy | WILLIAMS COS INC | $37,542,375 | +36.2% | 883,350 | +24.9% | 0.64% | +48.8% |
New | NEXTRACKER INC | $36,627,438 | – | 781,302 | +100.0% | 0.63% | – | |
SRPT | Buy | SAREPTA THERAPEUTICS INC | $36,107,582 | +105.9% | 228,529 | +68.7% | 0.62% | +124.7% |
SNPS | Sell | SYNOPSYS INC | $35,896,995 | -10.6% | 60,325 | -14.1% | 0.61% | -2.4% |
GLBE | Sell | GLOBAL E ONLINE LTD | $35,646,301 | -56.4% | 982,804 | -56.3% | 0.61% | -52.4% |
ORLY | Buy | OREILLY AUTOMOTIVE INC | $35,368,505 | -1.4% | 33,491 | +5.4% | 0.60% | +7.7% |
NTNX | Buy | NUTANIX INCcl a | $35,261,440 | +2664.0% | 620,254 | +2900.7% | 0.60% | +2920.0% |
ZNTL | Sell | ZENTALIS PHARMACEUTICALS INC | $34,960,895 | -80.8% | 8,547,896 | -26.2% | 0.60% | -79.1% |
ISRG | Buy | INTUITIVE SURGICAL INC | $33,486,084 | +11.5% | 75,275 | +0.1% | 0.57% | +21.7% |
CRNX | Sell | CRINETICS PHARMACEUTICALS IN | $32,924,592 | -33.6% | 735,088 | -30.6% | 0.56% | -27.5% |
DVAX | Buy | DYNAVAX TECHNOLOGIES CORP | $32,539,902 | -9.5% | 2,897,587 | +0.0% | 0.56% | -1.2% |
LSCC | Buy | LATTICE SEMICONDUCTOR CORP | $32,294,515 | -25.8% | 556,898 | +0.0% | 0.55% | -19.0% |
PWR | New | QUANTA SVCS INC | $31,991,710 | – | 125,907 | +100.0% | 0.55% | – |
HLI | Buy | HOULIHAN LOKEY INCcl a | $31,675,917 | +7.8% | 234,880 | +2.5% | 0.54% | +17.6% |
NARI | Sell | INARI MED INC | $29,836,099 | -44.7% | 619,649 | -44.9% | 0.51% | -39.6% |
ALV | Sell | AUTOLIV INC | $29,794,147 | -12.6% | 278,476 | -1.7% | 0.51% | -4.7% |
IRTC | Buy | IRHYTHM TECHNOLOGIES INC | $29,287,983 | +5.6% | 272,092 | +13.8% | 0.50% | +15.2% |
SHW | Buy | SHERWIN WILLIAMS CO | $29,199,883 | -11.5% | 97,845 | +3.0% | 0.50% | -3.3% |
STE | Buy | STERIS PLC | $29,000,575 | +30.5% | 132,097 | +33.6% | 0.50% | +42.1% |
GERN | New | GERON CORP | $26,950,212 | – | 6,356,182 | +100.0% | 0.46% | – |
IRM | Buy | IRON MTN INC DEL | $26,878,203 | +35.3% | 299,913 | +21.1% | 0.46% | +47.4% |
EGP | Buy | EASTGROUP PPTYS INC | $26,683,757 | -1.3% | 156,871 | +4.3% | 0.46% | +7.8% |
FIVN | Sell | FIVE9 INC | $25,561,154 | -41.6% | 579,618 | -17.8% | 0.44% | -36.2% |
SRRK | Buy | SCHOLAR ROCK HLDG CORP | $25,610,377 | -4.7% | 3,074,475 | +103.2% | 0.44% | +4.0% |
DV | Sell | DOUBLEVERIFY HLDGS INC | $25,502,195 | -69.1% | 1,309,820 | -44.2% | 0.44% | -66.2% |
RVMD | Buy | REVOLUTION MEDICINES INC | $25,258,557 | +117.1% | 650,826 | +80.3% | 0.43% | +137.4% |
CELC | Buy | CELCUITY INC | $25,143,300 | -16.3% | 1,535,000 | +10.4% | 0.43% | -8.7% |
KRYS | KRYSTAL BIOTECH INC | $25,064,105 | +3.2% | 136,485 | 0.0% | 0.43% | +12.6% | |
BPMC | BLUEPRINT MEDICINES CORP | $24,971,009 | +13.6% | 231,685 | 0.0% | 0.43% | +23.8% | |
AVB | New | AVALONBAY CMNTYS INC | $24,656,736 | – | 119,178 | +100.0% | 0.42% | – |
PNR | Buy | PENTAIR PLC | $24,390,184 | -9.9% | 318,119 | +0.4% | 0.42% | -1.4% |
NTAP | Buy | NETAPP INC | $23,732,173 | +114.3% | 184,256 | +74.6% | 0.41% | +133.3% |
VRSK | Buy | VERISK ANALYTICS INC | $22,948,948 | +64.9% | 85,138 | +44.2% | 0.39% | +80.3% |
KROS | Sell | KEROS THERAPEUTICS INC | $22,813,806 | -49.3% | 499,208 | -26.6% | 0.39% | -44.6% |
SO | Buy | SOUTHERN CO | $22,604,906 | +86.6% | 291,413 | +72.6% | 0.39% | +103.7% |
Buy | BIOHAVEN LTD | $22,029,187 | +0.4% | 634,664 | +58.2% | 0.38% | +9.6% | |
ESI | Buy | ELEMENT SOLUTIONS INC | $21,753,305 | +18.0% | 802,113 | +8.7% | 0.37% | +28.7% |
WDAY | Buy | WORKDAY INCcl a | $21,637,702 | -16.1% | 96,787 | +2.4% | 0.37% | -8.4% |
UTHR | New | UNITED THERAPEUTICS CORP DEL | $21,605,654 | – | 67,825 | +100.0% | 0.37% | – |
ALNY | ALNYLAM PHARMACEUTICALS INC | $21,141,000 | +62.6% | 87,000 | 0.0% | 0.36% | +77.5% | |
PEG | Buy | PUBLIC SVC ENTERPRISE GRP IN | $21,100,015 | +36.4% | 286,296 | +23.6% | 0.36% | +48.6% |
NOVT | Buy | NOVANTA INC | $20,617,756 | -6.6% | 126,404 | +0.0% | 0.35% | +2.0% |
CERE | CEREVEL THERAPEUTICS HLDNG I | $20,036,100 | -3.3% | 490,000 | 0.0% | 0.34% | +5.5% | |
RPRX | Buy | ROYALTY PHARMA PLC | $19,767,743 | -5.8% | 749,630 | +8.5% | 0.34% | +2.7% |
Buy | MOBILEYE GLOBAL INC | $18,912,608 | -6.8% | 673,406 | +6.7% | 0.32% | +1.9% | |
FDMT | Buy | 4D MOLECULAR THERAPEUTICS IN | $18,495,485 | -25.2% | 881,157 | +13.5% | 0.32% | -18.3% |
BBIO | BRIDGEBIO PHARMA INC | $18,159,761 | -18.1% | 716,927 | 0.0% | 0.31% | -10.6% | |
Sell | KORRO BIO INC | $17,922,480 | -63.0% | 529,155 | -1.6% | 0.31% | -59.6% | |
APTV | Buy | APTIV PLC | $17,659,998 | -11.6% | 250,781 | +0.0% | 0.30% | -3.5% |
INZY | Buy | INOZYME PHARMA INC | $17,555,541 | -27.9% | 3,936,220 | +23.8% | 0.30% | -21.2% |
R1 RCM INC | $17,282,309 | -2.5% | 1,375,980 | 0.0% | 0.30% | +6.5% | ||
DYN | New | DYNE THERAPEUTICS INC | $17,115,650 | – | 485,000 | +100.0% | 0.29% | – |
INSP | INSPIRE MED SYS INC | $16,740,795 | -37.7% | 125,090 | 0.0% | 0.29% | -31.8% | |
RCKT | Buy | ROCKET PHARMACEUTICALS INC | $16,592,977 | +25.5% | 770,691 | +57.0% | 0.28% | +37.2% |
MSCI | Sell | MSCI INC | $16,030,231 | -63.9% | 33,275 | -58.0% | 0.27% | -60.6% |
AIT | Buy | APPLIED INDL TECHNOLOGIES IN | $15,615,642 | +51.2% | 80,493 | +53.9% | 0.27% | +64.8% |
Buy | REMITLY GLOBAL INC | $15,357,434 | -28.0% | 1,267,115 | +23.2% | 0.26% | -21.5% | |
RNA | New | AVIDITY BIOSCIENCES INC | $15,356,495 | – | 375,924 | +100.0% | 0.26% | – |
RGEN | REPLIGEN CORP | $15,001,140 | -31.5% | 119,000 | 0.0% | 0.26% | -25.1% | |
IP | New | INTERNATIONAL PAPER CO | $14,644,981 | – | 339,397 | +100.0% | 0.25% | – |
ANAB | Buy | ANAPTYSBIO INC | $14,242,199 | +48.1% | 568,324 | +33.1% | 0.24% | +61.6% |
KYMR | Buy | KYMERA THERAPEUTICS INC | $13,793,655 | +1635.2% | 462,099 | +2236.9% | 0.24% | +1866.7% |
CYTK | CYTOKINETICS INC | $13,769,739 | -22.7% | 254,148 | 0.0% | 0.24% | -15.4% | |
IEX | Buy | IDEX CORP | $13,481,808 | -17.2% | 67,007 | +0.5% | 0.23% | -9.4% |
VKTX | VIKING THERAPEUTICS INC | $13,409,887 | -35.4% | 252,969 | 0.0% | 0.23% | -29.2% | |
TGTX | TG THERAPEUTICS INC | $12,787,701 | +17.0% | 718,814 | 0.0% | 0.22% | +28.1% | |
FSLR | New | FIRST SOLAR INC | $12,490,259 | – | 55,399 | +100.0% | 0.21% | – |
VCYT | VERACYTE INC | $12,221,880 | -2.2% | 564,000 | 0.0% | 0.21% | +6.6% | |
GPI | Buy | GROUP 1 AUTOMOTIVE INC | $12,214,641 | +25.9% | 41,088 | +23.8% | 0.21% | +37.5% |
ARWR | Buy | ARROWHEAD PHARMACEUTICALS IN | $12,056,605 | +34.6% | 463,894 | +48.1% | 0.21% | +46.1% |
COGT | New | COGENT BIOSCIENCES INC | $11,793,503 | – | 1,398,992 | +100.0% | 0.20% | – |
IDYA | IDEAYA BIOSCIENCES INC | $11,761,850 | -20.0% | 335,000 | 0.0% | 0.20% | -13.0% | |
Sell | CONSTELLATION ENERGY CORP | $11,142,222 | -3.5% | 55,636 | -11.0% | 0.19% | +5.5% | |
COG | New | COTERRA ENERGY INC | $11,166,329 | – | 418,685 | +100.0% | 0.19% | – |
Buy | GXO LOGISTICS INCORPORATED | $11,152,117 | -6.0% | 220,834 | +0.0% | 0.19% | +2.7% | |
CBT | Buy | CABOT CORP | $9,423,044 | +0.0% | 102,547 | +0.4% | 0.16% | +8.8% |
NKTR | New | NEKTAR THERAPEUTICS | $9,336,079 | – | 7,529,096 | +100.0% | 0.16% | – |
RLI | Buy | RLI CORP | $8,810,430 | +70.2% | 62,623 | +79.6% | 0.15% | +86.4% |
SYY | Buy | SYSCO CORP | $8,623,127 | -11.7% | 120,789 | +0.4% | 0.15% | -3.3% |
BRKR | Sell | BRUKER CORP | $8,410,924 | -57.4% | 131,812 | -37.3% | 0.14% | -53.5% |
APLS | APELLIS PHARMACEUTICALS INC | $8,047,698 | -34.7% | 209,794 | 0.0% | 0.14% | -28.5% | |
FANG | Sell | DIAMONDBACK ENERGY INC | $7,641,252 | -35.2% | 38,170 | -35.9% | 0.13% | -29.2% |
VRNA | Sell | VERONA PHARMA PLCsponsored ads | $7,631,713 | -78.3% | 527,781 | -75.9% | 0.13% | -76.3% |
GKOS | New | GLAUKOS CORP | $7,520,196 | – | 63,542 | +100.0% | 0.13% | – |
CMS | Sell | CMS ENERGY CORP | $7,443,214 | -26.9% | 125,033 | -25.9% | 0.13% | -20.6% |
SRE | Buy | SEMPRA | $5,999,309 | +6.4% | 78,876 | +0.5% | 0.10% | +17.0% |
Buy | LINDE PLC | $5,874,788 | +51.7% | 13,388 | +60.5% | 0.10% | +65.6% | |
SNV | Sell | SYNOVUS FINL CORP | $5,480,188 | -21.3% | 136,357 | -21.5% | 0.09% | -13.8% |
SPGI | Buy | S&P GLOBAL INC | $4,978,252 | +44.7% | 11,162 | +38.0% | 0.08% | +57.4% |
TSM | Buy | TAIWAN SEMICONDUCTOR MFG LTDsponsored ads | $4,301,624 | +30.9% | 24,749 | +2.4% | 0.07% | +42.3% |
PNFP | Buy | PINNACLE FINL PARTNERS INC | $3,630,294 | -6.2% | 45,356 | +0.6% | 0.06% | +1.6% |
VYNE THERAPEUTICS INC | $3,130,284 | 0.0% | 1,394,336 | 0.0% | 0.05% | +10.2% | ||
PCOR | PROCORE TECHNOLOGIES INC | $3,163,120 | -19.3% | 47,702 | 0.0% | 0.05% | -11.5% | |
OTIS | Buy | OTIS WORLDWIDE CORP | $2,933,716 | +190.0% | 30,477 | +199.1% | 0.05% | +212.5% |
EOG | Buy | EOG RES INC | $2,681,786 | +289.0% | 21,306 | +295.1% | 0.05% | +318.2% |
Sell | ARTERIS INC | $2,620,922 | -10.3% | 348,991 | -12.5% | 0.04% | -2.2% | |
METAGENOMI INC | $2,378,808 | -61.3% | 583,041 | 0.0% | 0.04% | -57.3% | ||
MDB | Sell | MONGODB INCcl a | $2,357,623 | -95.4% | 9,432 | -93.4% | 0.04% | -95.0% |
INTU | Buy | INTUIT | $2,351,497 | +51.2% | 3,578 | +49.5% | 0.04% | +66.7% |
AMGN | Buy | AMGEN INC | $2,239,954 | +60.7% | 7,169 | +46.2% | 0.04% | +72.7% |
NVDA | Buy | NVIDIA CORPORATION | $2,204,571 | +71.2% | 17,845 | +1152.3% | 0.04% | +90.0% |
Buy | NAYAX LTD | $1,873,676 | -18.3% | 87,554 | +0.4% | 0.03% | -11.1% | |
HD | New | HOME DEPOT INC | $1,815,522 | – | 5,274 | +100.0% | 0.03% | – |
NOW | Buy | SERVICENOW INC | $1,667,740 | +65.7% | 2,120 | +60.6% | 0.03% | +81.2% |
RSG | New | REPUBLIC SVCS INC | $1,581,150 | – | 8,136 | +100.0% | 0.03% | – |
UNP | Buy | UNION PAC CORP | $1,501,688 | +47.1% | 6,637 | +59.9% | 0.03% | +62.5% |
PRVA | Sell | PRIVIA HEALTH GROUP INC | $1,324,478 | -93.2% | 76,207 | -92.4% | 0.02% | -92.5% |
New | MIRUM PHARMACEUTICALS INCnote 4.000% 5/0 | $1,277,156 | – | 950,000 | +100.0% | 0.02% | – | |
TURNSTONE BIOLOGICS CORP | $1,200,791 | 0.0% | 458,317 | 0.0% | 0.02% | +10.5% | ||
New | RAPPORT THERAPEUTICS INC | $1,163,000 | – | 50,000 | +100.0% | 0.02% | – | |
MU | New | MICRON TECHNOLOGY INC | $1,119,715 | – | 8,513 | +100.0% | 0.02% | – |
LLY | Buy | ELI LILLY & CO | $1,070,159 | +57.4% | 1,182 | +35.2% | 0.02% | +63.6% |
FIVN | FIVE9 INCcall | $2,240 | -99.9% | 32,000 | 0.0% | 0.00% | -100.0% | |
WM | Exit | WASTE MGMT INC DEL | $0 | – | -7,982 | -100.0% | -0.03% | – |
INTA | Exit | INTAPP INC | $0 | – | -67,446 | -100.0% | -0.04% | – |
RCUS | Exit | ARCUS BIOSCIENCES INC | $0 | – | -240,000 | -100.0% | -0.07% | – |
Exit | TOURMALINE BIO INC | $0 | – | -320,916 | -100.0% | -0.12% | – | |
EQIX | Exit | EQUINIX INC | $0 | – | -12,357 | -100.0% | -0.16% | – |
MASS | Exit | 908 DEVICES INC | $0 | – | -1,430,995 | -100.0% | -0.17% | – |
AVTE | Exit | AEROVATE THERAPEUTICS INC | $0 | – | -445,500 | -100.0% | -0.21% | – |
ALPN | Exit | ALPINE IMMUNE SCIENCES INC | $0 | – | -408,542 | -100.0% | -0.25% | – |
RARE | Exit | ULTRAGENYX PHARMACEUTICAL IN | $0 | – | -359,000 | -100.0% | -0.26% | – |
Exit | MARINUS PHARMACEUTICALS INC | $0 | – | -2,346,526 | -100.0% | -0.33% | – | |
DLO | Exit | DLOCAL LTD | $0 | – | -3,362,993 | -100.0% | -0.78% | – |
SPT | Exit | SPROUT SOCIAL INC | $0 | – | -956,464 | -100.0% | -0.90% | – |
COUR | Exit | COURSERA INC | $0 | – | -4,515,809 | -100.0% | -0.99% | – |
SWAV | Exit | SHOCKWAVE MED INC | $0 | – | -507,418 | -100.0% | -2.59% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2024-08-13
About Eventide Asset Management
Eventide Asset Management is a Boston-based investment firm that specializes in providing investment solutions to investors who are looking for long-term growth opportunities. The company was founded in 2008 by a group of experienced investment professionals who shared a common vision of creating a firm that would focus on investing in companies that are making a positive impact on society.
The company's investment philosophy is based on the belief that companies that are making a positive impact on society are more likely to be successful in the long run. Eventide's investment team conducts extensive research to identify companies that are aligned with this philosophy and have the potential to deliver strong returns over the long term.
The company's investment strategies are managed by a team of experienced professionals, including CEO Robin John, COO Finny Kuruvilla, and Chief Investment Officer, Dr. Finny Kuruvilla. The team has a proven track record of delivering strong returns to investors, and their investment strategies have been recognized by industry experts.
Eventide Asset Management offers a range of investment solutions, including mutual funds, separately managed accounts, and exchange-traded funds (ETFs). The company's funds are available to individual investors, financial advisors, and institutional investors.
Overall, Eventide Asset Management is a reputable investment firm that has a strong focus on investing in companies that are making a positive impact on society. The company's experienced investment team and proven track record make it a compelling option for investors who are looking for long-term growth opportunities.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
LOWES COS INC | 43 | Q2 2024 | 3.2% |
PALO ALTO NETWORKS INC | 43 | Q2 2024 | 3.6% |
ASML HOLDINGS NV | 43 | Q2 2024 | 1.9% |
REPLIGEN CORP | 43 | Q2 2024 | 0.5% |
VERACYTE INC | 41 | Q2 2024 | 1.5% |
NEUROCRINE BIOSCIENCES INC | 40 | Q3 2023 | 1.1% |
LAM RESEARCH CORP | 38 | Q2 2024 | 3.4% |
COLLEGIUM PHARMACEUTICAL INC | 37 | Q2 2024 | 2.6% |
BLUEPRINT MEDICINES CORP | 36 | Q2 2024 | 1.3% |
XPO LOGISTICS INC | 34 | Q1 2023 | 3.8% |
View Eventide Asset Management's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
908 Devices Inc. | February 14, 2024 | 1,430,995 | 4.4% |
Annexon, Inc.Sold out | February 14, 2024 | 0 | 0.0% |
Celldex Therapeutics, Inc. | February 14, 2024 | 3,630,013 | 6.6% |
COLLEGIUM PHARMACEUTICAL, INC | February 14, 2024 | 2,630,478 | 8.1% |
Freeline Therapeutics Holdings plcSold out | February 14, 2024 | 0 | 0.0% |
Inozyme Pharma, Inc. | February 14, 2024 | 3,179,837 | 5.2% |
Korro Bio, Inc. | February 14, 2024 | 546,325 | 6.8% |
MARINUS PHARMACEUTICALS, INC. | February 14, 2024 | 4,529,997 | 8.3% |
Mirum Pharmaceuticals, Inc. | February 14, 2024 | 2,693,581 | 5.8% |
Praxis Precision Medicines, Inc.Sold out | February 14, 2024 | 0 | 0.0% |
View Eventide Asset Management's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
N-PX | 2024-08-27 |
13F-HR | 2024-08-13 |
SC 13G/A | 2024-08-09 |
13F-HR | 2024-05-15 |
13F-HR/A | 2024-02-20 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
View Eventide Asset Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.